bioRxiv preprint doi: https://doi.org/10.1101/2020.09.07.286922; this version posted September 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. van Leeuwen et al Computational pharmacogenomics screen identifies synergistic statin-compound combinations as anti-breast cancer therapies Jenna van Leeuwen1,2, Wail Ba-Alawi1,2, Emily Branchard2, Joseph Longo1,2, Jennifer Silvester1,3, David W. Cescon1,4,5, Benjamin Haibe-Kains1,2,6,7,§, Linda Z. Penn1,2,§, Deena M.A. Gendoo8,§ 1Department of Medical Biophysics, University of Toronto, 101 College Street, Toronto, ON, Canada, M5G 1L7 2Princess Margaret Cancer Centre, University Health Network, 101 College Street, Toronto, ON, Canada, M5G 1L7 3Institut de Recherches Cliniques de Montréal, 110 Pine Avenue West, Montreal, QC, Canada, H2Q 1R7 4Campbell Family Institute for Breast Cancer Research, 620 University Avenue, Toronto, ON, Canada, M5G 2C1 5Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 27 King’s College Circle, Toronto, ON, Canada, M5S 1A1 6Department of Computer Science, University of Toronto, 10 King’s College Road, Toronto, ON, Canada, M5S 3G4 7Ontario Institute of Cancer Research, 661 University Avenue, Suite 510, Toronto, ON, Canada, M5G 0A3 8Centre for Computational Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK § Co-corresponding authors Address for correspondence: Regarding computational aspects, Dr. Haibe-Kains <Benjamin.Haibe-
[email protected]> and Dr. Gendoo <
[email protected]>; regarding statin aspects, Dr.